Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

BACKGROUND: A high-dose trivalent inactivated influenza vaccine was licensed in 2009 by the US Food and Drug Administration (FDA) on the basis of serological criteria. We sought to establish whether high-dose inactivated influenza vaccine was more effective for prevention of influenza-related visits...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Izurieta, Hector S, Thadani, Nicole, Shay, David K, Lu, Yun, Maurer, Aaron, Foppa, Ivo M, Franks, Riley, Pratt, Douglas, Forshee, Richard A, MaCurdy, Thomas, Worrall, Chris, Howery, Andrew E, Kelman, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834448/
https://ncbi.nlm.nih.gov/pubmed/25672568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(14)71087-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados